Publication details
Analýza nákladů na cílenou biologickou léčbu pacientů s metastatickým karcinomem ledviny
| Title in English | Economic Evaluation of Targeted Biologic Therapy in Metastatic Renal Cell Carcinoma |
|---|---|
| Authors | |
| Year of publication | 2010 |
| Type | Article in Periodical |
| Magazine / Source | Klinická onkologie |
| MU Faculty or unit | |
| Citation | |
| Web | http://www.linkos.cz/odbornici/vzdelavani/klin_onko.php |
| Field | Oncology and hematology |
| Keywords | pharmacoeconomics; targeted therapy; sunitinib; sorafenib; renal cell carcinoma |
| Description | Targeted bio logic therapy has been proven to be effective compared to the current therapy of metastatic renal cell carcinoma (mRCC) in clinical studies as well as in actual clinical practice, but its high cost is a potentially limiting factor. Since the local cost-effectiveness analysis is missing, we assessed the cost of sunitinib and sorafenib in the treatment of mRCC in a comprehensive cancer centre. |